Table A3.

Analysis results: Summary includes the posterior mean estimates (Est), the estimated posterior standard deviations (ESE), and the estimated 95% equal-tailed credible intervals (CI95).

	All Trials			CSP−999
Variable	Est	ESE	CI95	Est	ESE	CI95
Heroine Use (Ref: YES)
NO	−0.57	0.21	(−1.00, −0.16)
Years of Opiate Use	0.01	0.01	(−0.01, 0.02)	0.01	0.02	(−0.02, 0.04)
Mode of Opioid Abuse (Ref: IV)
Oral	−1.32	0.23	(−1.78, −0.88)	−1.21	0.48	(−2.11, −0.21)
Snorting	−0.14	0.10	(−0.35, 0.06)	−0.15	0.23	(−0.60, 0.29)
Smoking	−0.40	0.28	(−0.94, 0.09)	−0.57	0.78	(−2.37, 0.69)
Sublingual	−1.34	0.97	(−3.42, 0.16)
Other	0.02	0.41	(−0.82, 0.89)	−0.42	0.72	(−2.08, 0.74)
Cocaine Use (Ref: YES)
NO	−0.04	0.09	(−0.22, 0.12)	−0.17	0.28	(−0.69, 0.37)
Meth Use (Ref: NO)
YES	0.13	0.09	(−0.05, 0.31)	0.77	0.28	(0.24, 1.31)
Alcohol Use (Ref: YES)
NO	−0.12	0.10	(−0.33, 0.07)	−0.49	0.23	(−0.97, −0.04)
Tranquilizer Use (Ref: NO)
YES	0.07	0.10	(−0.14, 0.25)	0.38	0.24	(−0.06, 0.85)
Marijuana Use (Ref: YES)
NO	0.05	0.10	(−0.16, 0.25)	0.20	0.23	(−0.27, 0.64)
PCP Use (Ref: NO)
YES	−0.01	0.11	(−0.22, 0.21)	−0.07	0.28	(−0.60, 0.54)